Tran NN, Mynatt RP, Kaye KS, Zhao JJ, Pogue JM. Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia. Open Forum Infect Dis. 2023 Apr;10(4):ofad170. doi: 10.1093/ofid/ofad170.
Tran NN, Morrisette T, Jorgensen SCJ, Orench-Benvenutti JM, Kebriaei R. Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections. Pharmacotherapy. 2023 Aug;43(8):816-832. doi: 10.1002/phar.2806.
Brenneman R, Shirk MB, Liscynesky C, Tran N, Rozycki E. Pharmacist involvement in blood culture follow up for patients discharged from the emergency department. Am J Emerg Med. 2023 Oct;72:101-106. doi: 10.1016/j.ajem.2023.07.019.
Alosaimy S, Lagnf AM, … Tran N, et al. Nephrotoxicity of Vancomycin in Combination with Beta-lactam Agents: Ceftolozane-tazobactam vs. Piperacillin-tazobactam. Clin Infect Dis. 2022 Aug; ciac670. doi:10.1093/cid/ciac670
Tran N, Mills JP, Gandhi TN, Petty LA, Nagel JL, Patel T, Eschenauer GA, et al. Incorporating Preauthorization into Antimicrobial Stewardship Pharmacist Workflow Reduces Clostridioides difficile and Gastrointestinal Panel Testing. Infection Control & Hospital Epidemiology. 2020 Oct;41(10):1136-1141.doi:10.1017/ice.2020.236.
Tran N, Rybak MJ. Beta-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA. Antimicrobial Agents and Chemotherapy. 2018 June; 62 (6): 157-18. doi:10.1128/AAC.00157-18
Werth BJ, Barber KE, Tran N, Rybak MJ. Ceftobiprole and Ampicillin Increase Daptomycin Susceptibility in DAP Susceptible and Resistant Vancomycin Resistant Enterococci. Journal of Antimicrobial Chemotherapy 2015 Feb; 70 (2): 489-493. doi:10.1093/jac/dku386
Specialty Practice Pharmacist, Infectious Diseases; Immunocompromised ID Lead at the James Cancer Hospital